Drug

Pharmaceutical companies are expecting higher growth from the American market in 2016-17, with quicker product approvals and launch of well-selling...

The Indian Pharmaceutical Alliance (IPA), an umbrella body of domestic generic drug makers, is preparing data integrity guidelines for companies...

Drug maker Lupin would not scale down its operations in emerging markets despite currency fluctuations and the company would look...

In a move to enhance its diabetes portfolio in India, US pharma major Eli Lilly has launched once-a-week diabetes treatment...

Five healthcare majors including Procter and Gamble, Glenmark and Reckitt Benckiser on Wednesday got interim relief from the Delhi high...

Even as the drug regulator of the country has withdrawn an alert on ophthalmic use of its cancer drug Avastin(bevacizumab),...

Most doctors seem to agree with grandma that you can live without cough syrups. Yet, the market currently has at...

Chennai-based Orchid Pharma has received final approval from the US Food and Drug Administration (USFDA) for its generic version of...

The government has banned as many as 1,670 drug brands, estimated total annual sales of Rs 3,728 crore, an analysis...

The Delhi High Court on Monday extended the stay on the government's decision to ban 344 fixed drug combinations (FDCs)...

Indoco Remedies has rallied 19% to Rs 314 on the National Stock Exchange (NSE) after the company received US Food...

The next time you have fever which refuses to come down despite medication, blame it on the medicine. Chances are...